If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Data Management and Biostatics
Download FREE Excerpt
16 Info Graphics
25 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Regulators, payers, physicians and patients are increasingly demanding evidence to demonstrate the effectiveness of new medicines, and pharmaceutical companies have turned to their Medical Affairs function to generate valuable insights from real world data and to communicate it to these stakeholders.
To accomplish this, Medical Affairs leaders need to collaborate with various internal teams as well as define guidelines governing the use of real world data to avoid compliance risks. In addition, effective Medical Affairs' programs around generating outcomes data include some type of performance measurement system.
Best Practices, LLC undertook benchmarking research to understand Medical Affairs' role and responsibilities in executing real world data programs and the key performance indicators organizations use to measure the success of a real world data program.
This study contains two segments: Regional Segment: US-Only (N= 8), Global (N= 12) and Company-Size Segments: Large Companies (N= 18) and Small and Mid-sized Companies (N= 10).
Best Practices, LLC engaged 28 Medical Affairs leaders from 23 leading biopharmaceutical companies through a benchmarking survey. More than 75% of participants serve at the director level or above.